Zheng ZN, Ye XH, Shen XB, Li T, Guo J. Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates. World J Oncol [Internet]. 2026 Jan. 1 [cited 2026 Apr. 21];17(2):129-42. Available from: https://wjon.elmerpub.com/wjon/article/view/2718